Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
GROWLIFE, INC. (PHOT)
|
Add to portfolio |
|
|
|
| Price: |
$0.02
| | Metrics |
| OS: |
33.8
|
M
| |
|
|
| Market cap: |
$540.4
|
k
| |
|
|
|
Net debt:
|
$4.6
|
M
| |
|
|
|
EV:
|
$5.14
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($2.6)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 6.2 | 7.0 | 8.2 | 4.6 | 2.5 | 1.2 | 3.5 | 0.0 |
| Revenue growth | -11.5% | -14.8% | 79.7% | 86.5% | 99.2% | -64.8% | | -100.0% |
| Cost of goods sold | 3.4 | 4.0 | 5.7 | 4.1 | 2.2 | 1.3 | 3.0 | 0.0 |
| Gross profit | 2.8 | 3.0 | 2.5 | 0.5 | 0.3 | 0.0 | 0.5 | 0.0 |
| Gross margin | 45.1% | 42.6% | 31.0% | 10.2% | 11.1% | -3.6% | 14.8% | |
| Selling, general and administrative | 0.0 | 0.0 | | | | | | 0.0 |
| General and administrative | 0.0 | 0.0 | 7.0 | 5.0 | 2.3 | 1.9 | 2.7 | 0.0 |
| EBITA | -0.9 | -1.2 | -3.6 | -4.5 | -2.0 | -2.8 | -4.2 | 0.0 |
| EBITA margin | -13.8% | -17.4% | -44.1% | -97.7% | -83.6% | -228.1% | -121.3% | |
| Amortization of intangibles | 0.7 | 0.7 | 0.8 | 0.1 | | | | |
| EBIT | -1.5 | -1.9 | -4.5 | -4.6 | -2.0 | -2.8 | -4.2 | 0.0 |
| EBIT margin | -24.6% | -27.0% | -54.3% | -100.8% | -83.6% | -228.1% | -121.3% | |
| Pre-tax income | 0.0 | -0.2 | -7.5 | -11.5 | -5.3 | -7.7 | -5.7 | 0.0 |
| Income taxes | 0.0 | 0.2 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | | 1.6% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Net income | -5.5 | -6.4 | -7.3 | -11.4 | -5.3 | -7.7 | -5.7 | 0.0 |
| Net margin | -88.3% | -91.1% | -88.7% | -250.2% | -217.0% | -624.9% | -162.6% | |
| |
| Diluted EPS | ($0.07) | ($0.17) | ($0.29) | ($0.58) | $0.00 | ($0.01) | ($0.01) | $0.00 |
| Shares outstanding (diluted) | 83.8 | 35.3 | 25.1 | 19.9 | 2,044.5 | 1,197.6 | 884.3 | 834.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|